BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10506577)

  • 1. Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls.
    Miosge N; Sasaki T; Timpl R
    FASEB J; 1999 Oct; 13(13):1743-50. PubMed ID: 10506577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo.
    Miosge N; Simniok T; Sprysch P; Herken R
    J Histochem Cytochem; 2003 Mar; 51(3):285-96. PubMed ID: 12588956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropoelastin binding to fibulins, nidogen-2 and other extracellular matrix proteins.
    Sasaki T; Göhring W; Miosge N; Abrams WR; Rosenbloom J; Timpl R
    FEBS Lett; 1999 Oct; 460(2):280-4. PubMed ID: 10544250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin.
    Sasaki T; Larsson H; Kreuger J; Salmivirta M; Claesson-Welsh L; Lindahl U; Hohenester E; Timpl R
    EMBO J; 1999 Nov; 18(22):6240-8. PubMed ID: 10562536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity.
    Sasaki T; Larsson H; Tisi D; Claesson-Welsh L; Hohenester E; Timpl R
    J Mol Biol; 2000 Sep; 301(5):1179-90. PubMed ID: 10966814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin.
    Sasaki T; Fukai N; Mann K; Göhring W; Olsen BR; Timpl R
    EMBO J; 1998 Aug; 17(15):4249-56. PubMed ID: 9687493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding.
    Chang Z; Choon A; Friedl A
    Am J Pathol; 1999 Jul; 155(1):71-6. PubMed ID: 10393839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin.
    Hopf M; Göhring W; Kohfeldt E; Yamada Y; Timpl R
    Eur J Biochem; 1999 Feb; 259(3):917-25. PubMed ID: 10092882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen XVIII/endostatin structure and functional role in angiogenesis.
    Zatterstrom UK; Felbor U; Fukai N; Olsen BR
    Cell Struct Funct; 2000 Apr; 25(2):97-101. PubMed ID: 10885579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological role of collagen XVIII and endostatin.
    Marneros AG; Olsen BR
    FASEB J; 2005 May; 19(7):716-28. PubMed ID: 15857886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
    Brown JC; Sasaki T; Göhring W; Yamada Y; Timpl R
    Eur J Biochem; 1997 Nov; 250(1):39-46. PubMed ID: 9431988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing.
    Bloch W; Huggel K; Sasaki T; Grose R; Bugnon P; Addicks K; Timpl R; Werner S
    FASEB J; 2000 Dec; 14(15):2373-6. PubMed ID: 11024009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminin modulates morphogenic properties of the collagen XVIII endostatin domain.
    Javaherian K; Park SY; Pickl WF; LaMontagne KR; Sjin RT; Gillies S; Lo KM
    J Biol Chem; 2002 Nov; 277(47):45211-8. PubMed ID: 12237301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-heparan sulfate-binding interactions of endostatin/collagen XVIII in murine development.
    Rychkova N; Stahl S; Gaetzner S; Felbor U
    Dev Dyn; 2005 Feb; 232(2):399-407. PubMed ID: 15614762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins.
    Talts JF; Andac Z; Göhring W; Brancaccio A; Timpl R
    EMBO J; 1999 Feb; 18(4):863-70. PubMed ID: 10022829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice.
    Li Q; Olsen BR
    Am J Pathol; 2004 Aug; 165(2):415-24. PubMed ID: 15277216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of collagen XVIII/endostatin results in eye abnormalities.
    Fukai N; Eklund L; Marneros AG; Oh SP; Keene DR; Tamarkin L; Niemelä M; Ilves M; Li E; Pihlajaniemi T; Olsen BR
    EMBO J; 2002 Apr; 21(7):1535-44. PubMed ID: 11927538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of nidogen binding sites for collagen type IV, heparan sulfate proteoglycan, and zinc.
    Reinhardt D; Mann K; Nischt R; Fox JW; Chu ML; Krieg T; Timpl R
    J Biol Chem; 1993 May; 268(15):10881-7. PubMed ID: 8496153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment.
    Lin HC; Chang JH; Jain S; Gabison EE; Kure T; Kato T; Fukai N; Azar DT
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2517-24. PubMed ID: 11581192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage.
    Pufe T; Petersen WJ; Miosge N; Goldring MB; Mentlein R; Varoga DJ; Tillmann BN
    Matrix Biol; 2004 Aug; 23(5):267-76. PubMed ID: 15464359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.